Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2005
05/19/2005US20050106591 Generating preferential RNA sequences via primer hybridization, transcription and recovery; preparing CDNA libraries; gene expression and analysis
05/19/2005US20050106590 Preparing preferential nucleotide sequences using overlapping regions and frameshift vectors; gene expression analysis
05/19/2005US20050106589 Elution with quaternary onium containing compound
05/19/2005US20050106587 Using immobilized probes as tools in detection preferential nucleotide sequences; gene expression analysis
05/19/2005US20050106586 Detection of neurodegenerative diseases
05/19/2005US20050106584 Alu-derived exons and uses thereof for detection and treatment of genetic diseases
05/19/2005US20050106583 Porous device
05/19/2005US20050106582 Transgenic cells comprising expression vectors coding transcription factors for use as tool in identifying modulators for prevention and treatment of cell proliferative, metabolic and immune disorders
05/19/2005US20050106581 Phosphodiesterase polypeptides for use in identifying modulators for prevention and treatment of inflammatory disease
05/19/2005US20050106578 Using probes specific to grampositive bacteria as tool in diagnosing/prognosing streptococcal infection; colorimetric analysis
05/19/2005US20050106577 Cleavable solid phases for isolating nucleic acids
05/19/2005US20050106576 Comprises matrix selected from silica, glass, insoluble synthetic polystyrene/polyacrylic acid, and insoluble polysaccharides; polymerase/ligase amplification
05/19/2005US20050106575 Using holliday junction specific primers as diagnostic tools in detection of single nucleotide polymorphisms; genotyping
05/19/2005US20050106574 Gelling agent and microsphere with nickel-complex coloring agent; immobilization
05/19/2005US20050106573 Method of detection of predisposition to high altitude pulmonary edema (HAPE)
05/19/2005US20050106572 Solid-state colorimetric biosensors comprised of dendritic polymer networks
05/19/2005US20050106571 Homodimeric taste receptor for use in identifying modulator of taste; food processing and flavors
05/19/2005US20050106569 Using concentration of paraneoplastic neuronal antigen (MA2) as diagnostic/prognostic risk indicator of nervous system disorders
05/19/2005US20050106568 Method of quantifying nucleic acid and kit for quantifying nucleic acid
05/19/2005US20050106567 Nucleotide sequences coding tau protein for use as diagnostic tool in detection of alzheimer's and neurodegenerative disorders
05/19/2005US20050106564 Automated single container reaction system to provide rapid, efficient means of detecting immunological interactions; immunoassay
05/19/2005US20050106563 Severe acute respiratory syndrome (SARS) coronaviral polypeptide for use in diagnosis, prevention and treatment of viral disease; viricides; genetic vaccines
05/19/2005US20050106561 Method for predicting the severity of viral hepatitis type B in patients treated with an anti-viral agent, and a kit for diagnosing viral hepatitis type B
05/19/2005US20050106560 selecting a host or replicator virus by by growing a population of viruses in a high selection pressure strain of bacteria where activity of interest confers a growth advantage; expanding the virus population, cycling the virus population through the process again
05/19/2005US20050106558 Generating viral expression vector comprising parvoviral structural genes for use as gene transfer and expression tool; treatment and prevention of infections, cell proliferative and autoimmune disorders
05/19/2005US20050106557 Using viscous suspension to measure cell motility in solution; swimming vs migration of cells
05/19/2005US20050106555 Method of screening for potential anti-bacterial agents
05/19/2005US20050106222 Genetic engineering; gene expression; polypeptides
05/19/2005US20050106217 Adjust fatty acid oxidation; stimulating carnitine palmitoyl transferase
05/19/2005US20050106142 Rheumatic arthritis; hepatitis c virus; autoimmune diseases ; nterfering with forming or binding of such; autoantigen
05/19/2005US20050106134 Pregnancy-related enzyme activity
05/19/2005US20050104698 Electromagnetic device, high-voltage generating device, and method for making the electromagnetic device
05/19/2005US20050103625 Sensor head for use with implantable devices
05/19/2005US20050103624 Biosensor and method of making
05/19/2005DE10349124A1 Use of hepicidin as marker of chronic inflammatory disease, useful particularly for differential diagnosis between inflammatory and non-inflammatory chronic diseases
05/19/2005DE10348407A1 Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben Prognostic and diagnostic markers for cell proliferative disorders of breast tissues
05/19/2005DE10347436A1 In vitro Verfahren zur Diagnose der kardiovaskulären Funktionalität von Knochenmarks-Vorläuferzellen (BMP) und/oder Blut-abgeleiteter zirkulierender Vorläuferzellen (BDP) An in vitro method for diagnosing the cardiovascular functionality of bone marrow precursor cells (BMP) and / or blood-derived circulating precursor cells (BDP)
05/19/2005DE10347400A1 Bisulfite conversion of DNA, involves reacting genomic DNA with bisulfite reagent, in presence of compound out of group of dioxane, one of its derivatives and similar aliphatic cyclic ether
05/19/2005DE10347399A1 Bisulfite conversion of DNA, involves reacting genomic DNA with bisulfite reagent, in presence of compound out of group of dioxane, one of its derivatives and similar aliphatic cyclic ether
05/19/2005DE10347397A1 Bisulfite conversion of DNA, involves reacting genomic DNA with bisulfite reagent, in presence of compound out of group of dioxane, one of its derivatives and similar aliphatic cyclic ether
05/19/2005DE10347396A1 Bisulfite conversion of DNA, involves reacting genomic DNA with bisulfite reagent, in presence of compound out of group of dioxane, one of its derivatives and similar aliphatic cyclic ether
05/19/2005DE102004049891A1 Verfahren zum Identifizieren von geeigneten Nukleinsäurenormalisierungssondensequenzen zur Verwendung bei Nukleinsäurearrays A method of identifying suitable nucleic acid probe sequences for use in normalization nucleic acid arrays
05/19/2005DE10154291B4 Verfahren zum Nachweis von Nukleinsäuren in Form eines Trockenschnelltestes A method for detecting nucleic acids in the form of a dry rapid test
05/19/2005CA2566823A1 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
05/19/2005CA2545171A1 Screening method with the use of tbk1 knockout mouse
05/19/2005CA2545160A1 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
05/19/2005CA2545115A1 Improvements relating to semen preservation
05/19/2005CA2544865A1 Cd20 antibodies with increased fc receptor binding affinity and effector function
05/19/2005CA2544848A1 Method of preventing virus: cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins
05/19/2005CA2544841A1 Pola dna polymerases capable of abasic site bypass
05/19/2005CA2544821A1 Simian orl1 gene and method of assessing compound
05/19/2005CA2544807A1 Compositions and methods of using apoptosis signaling kinase related kinase (askrk)
05/19/2005CA2544764A1 Protein binding miniature proteins
05/19/2005CA2544424A1 Electrochemical test strip for reducing the effect of direct interference current
05/19/2005CA2544178A1 Prenatal diagnosis using cell-free fetal dna in amniotic fluid
05/19/2005CA2543965A1 Gene expression and polymorphisms associated with lung cancer
05/19/2005CA2543961A1 Electrochemical test strip for reducing the effect of direct and mediated interference current
05/19/2005CA2543957A1 Method of reducing the effect of direct interference current in an electrochemical test strip
05/19/2005CA2543939A1 Rapid peptidoglycan-based assay for detection of bacterial contamination of platelets
05/19/2005CA2543860A1 Folate antagonists having improved selectivity
05/19/2005CA2543802A1 Method of reducing the effect of direct and mediated interference current in an electrochemical test strip
05/19/2005CA2543797A1 A method of reducing interferences in an electrochemical sensor using two different applied potentials
05/19/2005CA2543719A1 Methods and compositions for modulating apoptosis
05/19/2005CA2543586A1 A method for monitoring the presence of biofilm-forming microorganisms in paper industry
05/19/2005CA2543115A1 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
05/19/2005CA2542893A1 Combinatorial lubricating oil composition libraries
05/19/2005CA2542018A1 Radioactive multiplexing analytical methods
05/19/2005CA2537759A1 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells
05/19/2005CA2535153A1 Sample preparation methods and devices
05/18/2005EP1531184A2 Genetic testing kit and method for bladder cancer
05/18/2005EP1531183A1 Method for amplification of RNA sequences
05/18/2005EP1531180A1 Method of diagnosing risk of myocardial infarction
05/18/2005EP1530972A2 Use of an agent produced from a parasite for prevention and control of diseases
05/18/2005EP1530726A1 Caspase 10 as target for monitoring and treatment of diseases
05/18/2005EP1530725A1 Materials and methods for inductions of immune tolerance
05/18/2005EP1530724A2 Diagnosis and prevention of cancer cell invasion
05/18/2005EP1530710A2 A disposable cartridge for characterizing particles suspended in a liquid
05/18/2005EP1530644A2 Probes for detecting tumor cells
05/18/2005EP1530637A2 Subtilisin carlsberg proteins with reduced immunogenicity
05/18/2005EP1530635A2 Ghrelin binding nucleic acids
05/18/2005EP1530634A2 Modified shine-dalgarno sequences and methods of use thereof
05/18/2005EP1530632A2 Growth factor which acts through erb b-4 rtk
05/18/2005EP1530626A1 Determination and/or control of reactor environmental conditions
05/18/2005EP1530586A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
05/18/2005EP1530584A2 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
05/18/2005EP1530583A2 Novel calpastatin (cast) alleles
05/18/2005EP1530582A2 Diagnosis of kidney damage and protection against same
05/18/2005EP1530581A2 Polymeric label molecules
05/18/2005EP1530578A2 Modified nucleotides for polynucleotide sequencing
05/18/2005EP1530505A2 Pipette configurations and arrays thereof for measuring cellular electrical properties
05/18/2005EP1530483A2 T cell receptor cdr3 sequences and methods for detection
05/18/2005EP1530418A2 Methods of identifying and isolating stem cells and cancer stem cells
05/18/2005EP1456413A4 Method of detection of prostate cancer
05/18/2005EP1442141A4 Methods for identifying differentially expressed genes by multivariate analysis of microarry data
05/18/2005EP1409454A4 Increasing bioavailability of carotenoids
05/18/2005EP1353936A4 Primers and methods for the detection and discrimination of nucleic acids
05/18/2005EP1341909B1 A method for in vitro molecular evolution of protein function
05/18/2005EP1145011B1 Compositions and methods for the diagnosis and treatment of tumor
05/18/2005EP1066402B1 Methods of screening agents for activity using teleosts
05/18/2005EP0988398A4 Nucleic acid arrays
1 ... 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 ... 3003